Multiple sclerosis treatment: Is combination therapy effective?

content provided by

Multiple sclerosis treatment: Is combination therapy effective?


What can you tell me about combination therapy as a multiple sclerosis treatment option? Is it effective?

Ana Maria


Combination therapy most often refers to the use of two or more medications to treat a single disease. Scientists are studying the potential benefits of combination drug therapy in multiple sclerosis treatment.

Interferon beta-1a (Avonex, Rebif) and glatiramer (Copaxone) are two drugs currently used to treat relapsing remitting multiple sclerosis (MS). Each drug works in a different way, and both are generally considered mildly to moderately effective in reducing MS symptoms.

To determine whether these two drugs used in combination may provide a greater benefit than either drug used alone, a randomized, double-blind, multicenter study is under way. The study — which addresses the safety as well as the effectiveness of the drug combination — began in 2005. Results are expected in 2012.

Until study results are released, it's unclear what role — if any — combination drug therapy may play in routine multiple sclerosis treatment.

Last Updated: 2008-10-30
© 1998-2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "," "Mayo Clinic Health Information," "Reliable information for a healthier life" and the triple-shield Mayo logo are trademarks of Mayo Foundation for Medical Education and Research.

Terms and conditions of use


Bookmark and Share   E-Mail Page   Printer Friendly Version